243 Real world exposure survival relationship of pembrolizumab in metastatic melanoma

243 Real world exposure survival relationship of pembrolizumab in metastatic melanoma

Bibliographic Details
Main Authors:	Vishal Navani, Moira Graves, Giovana Marchett, Hiren Mandaliya, Nikola Bowden, Andre Van der Westhuizen
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2020-11-01
Series:	Journal for ImmunoTherapy of Cancer

Similar Items

Overall survival in metastatic melanoma correlates with pembrolizumab exposure and T cell exhaustion markers
by: Vishal Navani, et al.
Published: (2021-08-01)

Monitoring Patient Response to Pembrolizumab With Peripheral Blood Exhaustion Marker Profiles
by: Moira Graves, et al.
Published: (2019-05-01)

PEMBROLIZUMAB IN THE TREATMENT OF METASTATIC MELANOMA
by: I. V. SAMOILENKO, et al.
Published: (2017-06-01)

Lichen planopilaris associated with pembrolizumab in a patient with metastatic melanoma
by: Anna L. Cogen, MD, PhD, et al.
Published: (2018-03-01)

Efficacy of pembrolizumab for advanced/metastatic melanoma: a meta-analysis
by: Zhang Qi, et al.
Published: (2020-06-01)

Predicting response to pembrolizumab in metastatic melanoma by a new personalization algorithm
by: Neta Tsur, et al.
Published: (2019-10-01)

AIHA and Pancytopenia as Complications of Pembrolizumab Therapy for Metastatic Melanoma: A Case Report
by: Dan Ni, et al.
Published: (2019-06-01)

Coincident Metastatic Melanoma and Merkel Cell Carcinoma with Complete Remission on Treatment with Pembrolizumab
by: Alexander Thiem, et al.
Published: (2017-08-01)

The PEMDAC phase 2 study of pembrolizumab and entinostat in patients with metastatic uveal melanoma
by: Lars Ny, et al.
Published: (2021-08-01)

Retrospective analysis of treatment-naive Slovenian patients with metastatic melanoma treated with pembrolizumab – real-world experience
by: Hribernik Nezka, et al.
Published: (2020-01-01)

Pembrolizumab-Induced Psoriasis in Metastatic Melanoma: Activity and Safety of Apremilast, a Case Report
by: Maria Anna Siciliano, et al.
Published: (2020-10-01)

Metastatic melanoma with features of blue nevus and tumoral melanosis identified during pembrolizumab therapy
by: Matthew F. Helm, MD, et al.
Published: (2017-03-01)

Organizing pneumonia following treatment with pembrolizumab for metastatic malignant melanoma – A case report
by: R. Kuint, et al.
Published: (2017-01-01)

A case of pembrolizumab-induced severe DKA and hypothyroidism in a patient with metastatic melanoma
by: Osamah A Hakami, et al.
Published: (2019-03-01)

Single Center Experience Study with Pembrolizumab in Patients with BRAF Mutant Negative Metastatic Melanoma
by: Pejčić Ivica, et al.
Published: (2018-12-01)

Metastatic Eccrine Porocarcinoma: A Rare Case of Successful Treatment
by: Hiren Mandaliya, et al.
Published: (2016-08-01)

A Case of Severe Diabetic Ketoacidosis Associated with Pembrolizumab Therapy in a Patient with Metastatic Melanoma
by: Wu L, et al.
Published: (2021-02-01)

A Case of Acquired Generalized Lipodystrophy Associated with Pembrolizumab in a Patient with Metastatic Malignant Melanoma
by: Sara Bedrose, MD, et al.
Published: (2020-01-01)

Spotlight on pembrolizumab in the treatment of advanced melanoma
by: Rajakulendran T, et al.
Published: (2015-06-01)

Acute exudative polymorphous vitelliform maculopathy during pembrolizumab treatment for metastatic melanoma: a case report
by: Ine Lambert, et al.
Published: (2021-06-01)

Atypical Stevens–Johnson syndrome caused by pembrolizumab in the treatment of metastatic melanoma – Are corticosteroids a safe treatment option?
by: Cathal O'Connor, et al.
Published: (2020-01-01)

Long-term survival in multiresistant metastatic choriocarcinoma after pembrolizumab treatment: A case report
by: V. Paspalj, et al.
Published: (2021-08-01)

Pembrolizumab for the treatment of uveal melanoma: A case series
by: Yanina Jeanne Leona Jansen, et al.
Published: (2020-11-01)

Advanced melanoma in adults: Pembrolizumab as a treatment option
by: Antonio Silvinato, et al.

Vitiligo Repigmentation with Melanoma Progression During Pembrolizumab Treatment
by: Charlée Nardin, et al.
Published: (2019-07-01)

Challenging the standard of care in advanced melanoma: focus on pembrolizumab
by: Abdul-Karim RM, et al.
Published: (2017-09-01)

Remission of a Perimyocardial Melanoma Metastasis With Pembrolizumab Treatment
by: Frederik Uttenthal Larsen, MD, et al.
Published: (2019-06-01)

Safe Administration of Ipilimumab, Pembrolizumab, and Nivolumab in a Patient with Metastatic Melanoma, Psoriasis, and a Previous Guillain–Barré Syndrome
by: Alessio Cortellini, et al.
Published: (2018-01-01)

A Phase Ib Study of Pembrolizumab as Second-Line Therapy for Chinese Patients With Advanced or Metastatic Melanoma (KEYNOTE-151)
by: Lu Si, et al.
Published: (2019-06-01)

Choroid Melanoma Metastasis to Spine: A Rare Case Report
by: Hiren Mandaliya, et al.
Published: (2016-01-01)

Eftilagimod alpha, a soluble lymphocyte activation gene-3 (LAG-3) protein plus pembrolizumab in patients with metastatic melanoma
by: Christian Mueller, et al.
Published: (2020-07-01)

Enhancement of antiviral CD8 T-cell responses and complete remission of metastatic melanoma in an HIV-1 infected subject treated with pembrolizumab
by: O. Blanch-Lombarte, et al.
Published: (2019-12-01)

Treatment Considerations for Patients with Unresectable Metastatic Melanoma Who Develop Pembrolizumab-Induced Guillain-Barré Toxicity: A Case Report
by: Sivraj Muralikrishnan, et al.
Published: (2020-01-01)

Sequential decitabine and carboplatin treatment increases the DNA repair protein XPC, increases apoptosis and decreases proliferation in melanoma
by: Timothy Budden, et al.
Published: (2018-01-01)

New developments in the management of advanced melanoma – role of pembrolizumab
by: Improta G, et al.
Published: (2015-09-01)

Identification of neutralising pembrolizumab anti-drug antibodies in patients with melanoma
by: S. C. Sasson, et al.
Published: (2021-09-01)

Pembrolizumab in a Patient With a Metastatic CASTLE Tumor of the Parotid
by: Lisa Lorenz, et al.
Published: (2019-08-01)

Profile of pembrolizumab in the treatment of patients with unresectable or metastatic urothelial carcinoma
by: Inokuchi J, et al.
Published: (2019-05-01)

An extrauterine extensively metastatic epithelioid trophoblastic tumor responsive to pembrolizumab
by: Sarah G. Bell, et al.
Published: (2021-08-01)

Update on the role of pembrolizumab in patients with unresectable or metastatic colorectal cancer
by: Vanessa Wookey, et al.
Published: (2021-06-01)